News

Video

Overcoming Barriers to Treatment Access and Reimbursement

Author(s):

Nour Abuhadra, MD

Dr. Noor Abuhadra and patient Shay Elkins discuss overcoming barriers to cancer treatment access and reimbursement. Shay shares her relatively smooth experience with insurance coverage, while Dr. Abuhadra emphasizes that healthcare teams will fight for patient coverage, especially when treatments are backed by research and FDA approval. Dr. Abuhadra also mentions having a financial clearance department to handle denials and secure approvals, as well as training staff to fill out prior authorization forms. Shay underlines the importance of self-advocacy and leveraging online communities for both emotional support and practical advice.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Image of woman.
      Research Shines Light on Disparities Across Breast Cancer Care
      Image of Doctor.
      Dr. Sheri Prentiss on Steps for Lymphedema Screening in Breast Cancer
      Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
      Emphasizing the Importance of Breast Cancer Education and Screenings
      Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
      The Power of Knowledge and Staying Informed in Breast Cancer Care
      Image od grey haired Doctor.
      Kadcyla Continues to Show Benefits in Early HER2+ Breast Cancer
      Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
      How Antibody-Drug Conjugates Have Impacted HER2-Positive Breast Cancer Treatment
      Image of man with grey hair.
      The Role of Circulating Tumor DNA in Breast Cancer Monitoring
      Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer
      Dr. Kevin Kalinsky Covers Targeted Therapy in HER2– Breast Cancer
      Discussing the Mission of CURE With Our Former and New Editors-In-Chief
      Discussing the Mission of CURE With Our Former and New Editors-In-Chief
      Image of woman with blonde hair.
      Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
      Related Content
      Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
      March 28th 2025

      Life Goes On, Even With Breast Cancer

      Laura Yeager
      I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish others strength in their journeys.
      FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
      February 5th 2024

      FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

      Alex Biese Brielle Benyon
      One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
      Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
      March 27th 2025

      Snow, A Wig, and Memories After My Breast Cancer Diagnosis

      Bonnie Annis
      Cancer memories often sneak up on me when I least expect them to.
      Cancer Horizons podcast logo
      December 12th 2023

      Conference Highlights from SABCS

      Alex Biese Brielle Benyon
      CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
      Dr. Regina Hampton illustrates how genomic insights have improved patient outcomes in breast cancer: © stock.adobe.com
      March 23rd 2025

      Unraveling Disparities and Genomic Advances Across Breast Cancer Care

      Ryan Scott
      Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.
      Image of a pink ribbon.
      March 21st 2025

      Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer

      Ryan Scott
      Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.